Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
China
· Delayed Price · Currency is CNY 12.23
-0.11 (-0.89%)
Mar 11, 2026, 3:04 PM CST
SHE:000590 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -111.84 | -125.47 | 25.25 | 18.11 | 35.44 | 22.72 | Upgrade
|
| Depreciation & Amortization | 28.85 | 28.85 | 28.04 | 24.36 | 19.48 | 14.18 | Upgrade
|
| Other Amortization | 1.26 | 1.26 | 1.1 | 0.97 | 1.2 | 1.11 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | -0 | -13.33 | -0.02 | -0.51 | -0.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | 118.71 | 118.71 | 5.59 | 0.67 | 2.02 | 2.6 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.5 | 0.5 | -2.79 | -2.77 | -3.33 | -0.38 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | - | -1.25 | Upgrade
|
| Other Operating Activities | 8.29 | 2.7 | 4.99 | 2.07 | -1.86 | 0.2 | Upgrade
|
| Change in Accounts Receivable | -4.29 | -4.29 | -45.83 | 2.92 | -26.83 | -0.49 | Upgrade
|
| Change in Inventory | 5.13 | 5.13 | -11.64 | -7.33 | -35.57 | -0.38 | Upgrade
|
| Change in Accounts Payable | -32.03 | -32.03 | -28.32 | 15.52 | 35.66 | 15.68 | Upgrade
|
| Change in Other Net Operating Assets | 26.9 | 26.9 | 7.96 | -0.98 | -0.1 | - | Upgrade
|
| Operating Cash Flow | 36.61 | 17.39 | -29.39 | 54.47 | 25.2 | 51.48 | Upgrade
|
| Operating Cash Flow Growth | 558.85% | - | - | 116.20% | -51.06% | 76.25% | Upgrade
|
| Capital Expenditures | -38.43 | -32.1 | -22.04 | -18.68 | -25.88 | -33.91 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.14 | 0.01 | 0.2 | 2.67 | 0.71 | 0.2 | Upgrade
|
| Cash Acquisitions | - | - | - | -214.52 | - | - | Upgrade
|
| Investment in Securities | -3 | - | 25 | 50 | -94 | 0.38 | Upgrade
|
| Other Investing Activities | 0.66 | 0.54 | 0.99 | 2.99 | 3.18 | 5.6 | Upgrade
|
| Investing Cash Flow | -40.63 | -31.55 | 4.15 | -177.54 | -115.98 | -27.73 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 5 | Upgrade
|
| Long-Term Debt Issued | - | 38.11 | 20 | 130.8 | 0.05 | - | Upgrade
|
| Total Debt Issued | 48.75 | 38.11 | 20 | 130.8 | 0.05 | 5 | Upgrade
|
| Long-Term Debt Repaid | - | -38.22 | -48.13 | -20.94 | -7.79 | - | Upgrade
|
| Total Debt Repaid | -48.22 | -38.22 | -48.13 | -20.94 | -7.79 | - | Upgrade
|
| Net Debt Issued (Repaid) | 0.54 | -0.11 | -28.13 | 109.86 | -7.74 | 5 | Upgrade
|
| Common Dividends Paid | -3.41 | -3.47 | -4.2 | -0.34 | -0.06 | - | Upgrade
|
| Other Financing Activities | 4.72 | 0.26 | 0.82 | 2 | 2 | -0.14 | Upgrade
|
| Financing Cash Flow | 1.85 | -3.31 | -31.51 | 111.52 | -5.81 | 4.86 | Upgrade
|
| Net Cash Flow | -2.17 | -17.47 | -56.75 | -11.55 | -96.59 | 28.62 | Upgrade
|
| Free Cash Flow | -1.81 | -14.71 | -51.43 | 35.79 | -0.68 | 17.58 | Upgrade
|
| Free Cash Flow Margin | -0.52% | -4.29% | -12.71% | 10.21% | -0.23% | 6.39% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.06 | -0.21 | 0.15 | -0.00 | 0.07 | Upgrade
|
| Cash Interest Paid | - | - | - | - | - | 0.01 | Upgrade
|
| Cash Income Tax Paid | 42.62 | 36.36 | 52.07 | 32.68 | 32.78 | 43.46 | Upgrade
|
| Levered Free Cash Flow | -19.77 | -8.13 | -64.34 | 21.79 | -23.75 | 6.84 | Upgrade
|
| Unlevered Free Cash Flow | -17.59 | -5.84 | -61.55 | 22.52 | -23.45 | 6.85 | Upgrade
|
| Change in Working Capital | -9.14 | -9.14 | -78.24 | 11.08 | -27.24 | 12.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.